KOL | John L Cameron†Department of Surgery, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Halsted 614, 21287, Baltimore, MD, USA | Department of Surgery, Johns Hopkins School ... |
KOL Resume for John L Cameron†
| Year | |
|---|---|
| 2022 | Department of Surgery, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Halsted 614, 21287, Baltimore, MD, USA Johns Hopkins University School of Medicine, Baltimore, MD, United States. |
| 2021 | Johns Hopkins Medical Institutions and the Pancreatic Cancer Precision Medicine Center of Excellence Program, Baltimore, MD, USA. |
| 2020 | Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. The Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA |
| 2019 | Department of Surgery, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA The Pancreatic Cancer Precision Medicine Center of Excellence Program, Johns Hopkins University School of Medicine, Baltimore, MD. |
| 2018 | From the *Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; †Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Robert, Wood Johnson Medical School, Rutgers University, New Brunswick, NJ; ‡Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman, Pancreatic Cancer Research Center, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD; §Department of Radiation Oncology, University of Arizona Cancer Center, Tucson, AZ ∥Department of Radiology, The Sol Goldman Pancreatic Cancer Research Center, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD; ¶Department of Biostatistics, School of Public Health, Rutgers University; Biometrics Division, Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ; #Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD; **Department of Pathology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ; ††Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD; ‡‡Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH; §§Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD; and ∥∥Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY. Johns Hopkins University School of Medicine, Baltimore, MD; Surgery. |
| 2017 | Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD The Sol Goldman Pancreatic Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland |
| 2016 | Department of Surgery, Johns Hopkins Hospital, Baltimore, MD, USA |
| 2015 | Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA |
| 2014 | Departments of Surgery, Johns Hopkins University School of Medicine, 600 North Wolfe St, Halsted 608, 21287, Baltimore, MD, USA Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD |
| 2013 | Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland Division of Surgical Oncology, John Hopkins Hospital, 600 N. Wolfe Street, Blalock 688, 21287, Baltimore, MD, USA |
| 2012 | Surgery University of Maryland School of Medicine, Baltimore, MD; Johns Hopkins University School of Medicine, Baltimore, MD; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; University of Maryland Medical Systems, Baltimore, MD; The Johns Hopkins University School of Medicine, Baltimore, MD; Johns Hopkins University, Sidney Kimmel Cancer Center, Baltimore, MD; University of Maryland, Baltimore, MD; University of Maryland Greenebaum... |
| 2011 | The Sol Goldman Pancreatic Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA Johns Hopkins University School of Medicine, Baltimore, MD; University of California, San Francisco, San Francisco, CA; University of Texas M. D. Anderson Cancer Center, Houston, TX; Johns Hopkins University, Baltimore, MD; Johns Hopkins University, Sidney Kimmel Cancer Center, Baltimore, MD |
| 2010 | Department of Surgery, Johns Hopkins Medical Institutions, Harvey 611, 600N Wolfe Street, 21287, Baltimore, MD, USA |
John L Cameron†: Influence Statistics
| Concept | World rank |
|---|---|
| lrresultsa | #1 |
| patients endotracheal tubes | #1 |
| sensitivity nodal disease | #1 |
| preparations acute pancreatitis | #1 |
| preparations ischemic period | #1 |
| topical costs | #1 |
| bmpt | #1 |
| silastic transhepatic stents | #1 |
| patients pancreatic adenocarcinoma | #1 |
| cancers pancreatic body | #1 |
| actual mortality rate | #1 |
| morbidity pancreaticoduodenectomy | #1 |
| pancreatic nodal metastases | #1 |
| cholangiography tumor | #1 |
| carmethodsa | #1 |
| ampulla female follow | #1 |
| vater diagnosis | #1 |
| hospital charges period | #1 |
| lobe weight | #1 |
| total cost repair | #1 |
| modifications longmire procedure | #1 |
| superoxide dismutase injury | #1 |
| duct bifurcation | #1 |
| mortality rates period | #1 |
| pancreatoduodenectomy united states | #1 |
| 1 increase sensitivity | #1 |
| patients bismuth level | #1 |
| nonpancreatic primary cancers | #1 |
| factors pancreatic fistula | #1 |
| untreated poss glands | #1 |
| year 201 procedures | #1 |
| surgery cholangiocarcinoma | #1 |
| patients prophylactic octreotide | #1 |
| treatment choledochal cysts | #1 |
| palliative bypass time | #1 |
| internal pancreatic fistulae | #1 |
| young female admirer | #1 |
| poss frs | #1 |
| patients robotic pancreatectomy | #1 |
| iqr nodal disease | #1 |
| year anesthesiologist | #1 |
| pdresultsa | #1 |
| hospital share | #1 |
| patients postoperative stricture | #1 |
| mortality rate pancreaticoduodenectomy | #1 |
| surgery extrahepatic cholangiocarcinoma | #1 |
| pancreas preparation | #1 |
| nonrandomized reports | #1 |
| resection borderline | #1 |
| repeated treatment probability | #1 |
Open the FULL List in Excel | |
Prominent publications by John L Cameron†
OBJECTIVE: To update the authors' experience with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas.
BACKGROUND DATA: IPMNs are intraductal mucin-producing cystic neoplasms of the pancreas with clear malignant potential. Since the authors' 2001 report, the number of IPMNs resected at our institution has more than doubled, providing an opportunity to define the clinical features of this distinct neoplasm.
METHODS: All patients undergoing pancreatic resection for an IPMN at ...
| Known for Invasive Cancer | Patients Ipmns | Needle Carcinoma | Pancreatic Resection Ipmn | Mucinous Neoplasms |
Barrett's esophagus: Its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux
[ PUBLICATION ]
The pathologic reports of all 1,020 esophageal biopsy specimens obtained between 1975 and 1981 in patients with symptoms of gastroesophageal reflux were reviewed. Barrett's esophagus was identified in 84 patients (8 percent). The 362 patients seen between 1980 and 1981 were reviewed in detail. The symptoms in patients with Barrett's esophagus differed from those of the patients without Barrett's esophagus. Dysphagia was more often present in the former group (34 percent versus 16 ...
| Known for Gastroesophageal Reflux | Patients Barretts Esophagus | Hiatal Hernia | Esophageal Biopsy | Aged Barrett |
Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves Survival
[ PUBLICATION ]
OBJECTIVE: This study was designed to evaluate prospectively survival after pancreaticoduodenectomy for pancreatic adenocarcinoma, comparing two different postoperative adjuvant chemoradiation protocol to those of no adjuvant therapy.
SUMMARY BACKGROUND DATA: Based on limited data from the Gastrointestinal Tumor Study Group, adjuvant chemoradiation therapy has been recommended after pancreaticoduodenectomy for adenocarcinoma of the head, neck, or uncinate process of the pancrease. ...
| Known for Postoperative Adjuvant | Pancreatic Adenocarcinoma | Uncinate Process | Head Neck | Therapy Survival |
Pancreaticoduodenectomy With or Without Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma
[ PUBLICATION ]
OBJECTIVE: This prospective, randomized, single-institution trial was designed to evaluate the end points of mortality, morbidity, and survival in patients undergoing standard versus radical (extended) pancreaticoduodenectomy (including distal gastrectomy and retroperitoneal lymphadenectomy).
SUMMARY BACKGROUND DATA: Numerous retrospective reports and one prospective randomized trial have suggested that the performance of an extended lymphadenectomy in association with a ...
| Known for Periampullary Adenocarcinoma | Patients Radical | Extended Retroperitoneal | Standard Resection | Distal Gastrectomy |
Pancreatoblastomas are unusual malignant neoplasms of the pediatric pancreas that may also rarely affect adults. The molecular pathogenesis of pancreatoblastomas is unknown. They are clinicopathologically distinct from adult pancreatic ductal adenocarcinomas, but their occasional occurrence in patients with Beckwith-Wiedemann syndrome and the case presented here of a pancreatoblastoma in an adult patient with familial adenomatous polyposis (FAP) suggests that they might bear a genetic ...
| Known for Chromosome 11p | Genetic Alterations | Germ Cell | Catenin Pathway | P53 Genes |
OBJECTIVE: To evaluate, in a prospective, randomized single-institution trial, the end points of operative morbidity, operative mortality, and survival in patients undergoing standard versus radical (extended) pancreaticoduodenectomy.
SUMMARY BACKGROUND DATA: Numerous retrospective reports and a few prospective randomized trials have suggested that the performance of an extended lymphadenectomy in association with a pancreaticoduodenal resection may improve survival for patients with ...
| Known for Periampullary Adenocarcinoma | Distal Gastrectomy | Retroperitoneal Lymphadenectomy | Patients Radical | Standard Pancreaticoduodenectomy |
Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction
[ PUBLICATION ]
The prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction are uncertain. We studied 61 consecutive esophagogastrectomy specimens with adenocarcinoma, which were subjected to extensive histopathologic examination. Barrett esophagus was found in 64% of the cases (39 of 61), but had been recognized in only 38% of the patients with Barrett-associated carcinoma who had undergone preoperative endoscopy with biopsy (13 ...
| Known for Barrett Esophagus | Esophagogastric Junction | Patients Adenocarcinoma | Esophageal Neoplasms |
OBJECTIVES: We assess how laparoscopy has altered the presentation of patients with gallbladder cancer and determine whether radical resection in patients with gallbladder cancer is beneficial.
SUMMARY BACKGROUND DATA: The widespread adoption of laparoscopic cholecystectomy has led to an increased frequency of incidentally discovered gallbladder carcinoma. Little data exist to guide surgeons in the optimum management of patients with gallbladder cancer, particularly with respect to the ...
| Known for Gallbladder Cancer | Radical Resection | Laparoscopic Cholecystectomy | 5year Survival | Patients Incidentally |
Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
[ PUBLICATION ]
This large-volume, single-institution review examines factors influencing long-term survival after resection in patients with adenocarcinoma of the head, neck, uncinate process, body, or tail of the pancreas. Between January 1984 and July 1999 inclusive, 616 patients with adenocarcinoma of the pancreas underwent surgical resection. A retrospective analysis of a prospectively collected database was performed. Both univariate and multivariate models were used to determine the factors ...
| Known for Patients Adenocarcinoma | Prognostic Indicators | Uncinate Process | Head Neck | Tumor Location |
PURPOSE: Primary endpoints were 1. To determine if, in the context of postoperative adjuvant therapy of pancreatic and nonpancreatic periampullary adenocarcinoma, continuous infusion (C.I.) 5-fluorouracil (5-FU) and leucovorin (Lv), combined with continuous-course external-beam radiotherapy (EBRT) to liver (23.4-27.0 Gy), regional lymph nodes (50.4-54.0 Gy) and tumor bed (50.4-57.6 Gy), followed by 4 months of C.I. 5-FU/Lv without EBRT could be given with acceptable toxicity. 2. To ...
| Known for Adjuvant Therapy | 9 Levels | Patients Pancreatic Cancer | Periampullary Adenocarcinoma | Vater Antimetabolites |
Does Prophylactic Octreotide Decrease the Rates of Pancreatic Fistula and Other Complications After Pancreaticoduodenectomy?
[ PUBLICATION ]
OBJECTIVE: To evaluate the endpoints of complications (specifically pancreatic fistula and total complications) and death in patients undergoing pancreaticoduodenectomy.
SUMMARY BACKGROUND DATA: Four randomized, placebo-controlled, multicenter trials from Europe have evaluated prophylactic octreotide (the long-acting synthetic analog of native somatostatin) in patients undergoing pancreatic resection. Each trial reported significant decreases in overall complication rates, and two of the ...
| Known for Prophylactic Octreotide | Pancreatic Fistula | United States | Total Complications | Hospital Stay Patients |
BackgroundBased on data from other malignancies, the number of lymph nodes evaluated and the ratio of metastatic to examined lymph nodes (LNR) may be important predictors of survival. LNR has never been investigated in a large population-based study of patients with pancreatic adenocarcinoma.MethodsThe Surveillance, Epidemiology, and End Results (SEER) database was used to identify 4005 patients who underwent resection for pancreatic adenocarcinoma from 1988 to 2003. The effect of total ...
| Known for Pancreatic Adenocarcinoma | Lnr Survival | Lymph Node | N1 Disease | Resultsthe Median |
p16 Inactivation in Pancreatic Intraepithelial Neoplasias (PanINs) Arising in Patients With Chronic Pancreatitis
[ PUBLICATION ]
Patients with long-standing chronic pancreatitis are thought to be at increased risk of developing pancreatic ductal adenocarcinoma, but the mechanism for this increased risk is unknown. Since increasing evidence supports the notion that infiltrating pancreatic ductal adenocarcinomas arise from pancreatic intraepithelial lesions (PanINs), we sought to determine if patients with chronic pancreatitis harbor PanINs with alterations in tumor suppressor genes that are associated with ...
| Known for Chronic Pancreatitis | Patients Panins | Situ Carcinoma | Pancreatic Intraepithelial | P16 Expression |
We examined 82 surgically resected or biopsied, formalin-fixed, paraffin-embedded primary adenocarcinomas of the pancreas for the presence of activating point mutations in codon 12 of the K-ras oncogene. Mutations were detected using primer-mediated, mutant-enriched, polymerase chain reaction-restriction fragment length polymorphism analysis and characterized further by allele-specific oligonucleotide hybridization. This combination of mutant-enriched polymerase chain ...
| Known for Chain Reaction | Mutations Codon | Ras Oncogene | Specific Oligonucleotide | Human Pancreas |
Key People For Pancreatic Cancer
John L Cameron†:Expert Impact
Concepts for whichJohn L Cameron†has direct influence:Pancreatic cancer, Pancreatic adenocarcinoma, Acute pancreatitis, Surgical resection, Johns hopkins hospital, Chronic pancreatitis, Periampullary adenocarcinoma, Neoadjuvant therapy.
John L Cameron†:KOL impact
Concepts related to the work of other authors for whichfor which John L Cameron† has influence:Pancreatic cancer, Postoperative complications, Acute pancreatitis, Bile duct, Surgical resection, Distal pancreatectomy, Liver metastases.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |